Remove Food Remove Leads Remove Prescription Remove Side effects
article thumbnail

A scientific approach to irrational consumer choices

World of DTC Marketing

” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx? Ad recall is essential for CPGs, but for prescription drugs, the question that’s missing is “what action did it lead to? What people seem to be interested in are drug side effects vs. efficacy.

article thumbnail

The internet enables misinformation on COVID

World of DTC Marketing

While patients have the right to full disclosure, misinformation and scare tactics could lead to more deaths from COVID. The major concerns for hesitancy included worries over side effects and that the vaccine is too new. Also cited was a lack of trust in the government to ensure the vaccines’ safety and effectiveness.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Pharmacogenomics may finally realise its promise

pharmaphorum

More than 60 percent of all American adults take prescription drugs , amounting to approximately 131 million individuals. Identifying those variations helps to target medication changes that can be safer and more effective. This means that hyper-metabolisers would need their dosage to be increased to achieve the desired effect.

article thumbnail

Data Analytics Applications in Animal Health Bio-Technology

Celeritas

Predictive : future trends based on past trends Prescriptive : what to do based on the current situation and future likelihoods. Because drugs aren’t personalized, they often have irregular side effects. A highly accurate way to prescribe drugs could be made possible by prescriptive analytics.

Food 98
article thumbnail

FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom

Pharmaceutical Technology

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. There are only two marketed treatments for ALS in the US. The FDA’s action plan.

FDA 98
article thumbnail

Two Key Questions About Adherence/Compliance in 2022

PM360

Accordingly, multiple reasons for subpar patient adherence are gaining attention, including fear of side effects, lack of medical understanding, or even financial limitations. Housing, access to food and transportation, as well as the ability to pay for healthcare and medicine are just a few economic barriers to medical adherence.

Medical 105